Separately, Kepler Capital Markets set a €55.00 ($59.14) price objective on shares of Drägerwerk AG & Co. KGaA in a research note on Tuesday, January 11th.
Shares of ETR:DRW3 opened at €47.20 ($50.75) on Friday. The company has a market capitalization of $405.92 million and a price-to-earnings ratio of 6.47. Drägerwerk AG & Co. KGaA has a 52 week low of €46.45 ($49.95) and a 52 week high of €82.70 ($88.92). The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 27.66. The firm has a 50 day moving average of €50.59 and a 200 day moving average of €55.65.
Drägerwerk AG & Co KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- Iridium Communications Stock is Ready to Return to Orbit
Receive News & Ratings for Drägerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drägerwerk AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.